Cancer Registry Software Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Canada,Germany,Italy,China - Size and Forecast 2023-2027

Cancer Registry Software Market Forecast 2023-2027

The Global Cancer Registry Software Market size is estimated to grow by USD 82.3 million at a CAGR of 12.13% between 2022 and 2027. Cancer registries help to maintain and improve patient care and focus on clinical research. Registries for cancer are hospital-based and population-based cancer registries that are used in most countries across the globe. To reach goals such as early detection, understanding trends, prevention of cancer, understanding the patterns of treatment and outcome, and efforts to control cancer population-based registries are developed by government bodies.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

The market is witnessing significant growth driven by the rising incidence of cancer cases worldwide and the increasing need for efficient data management and analysis in cancer research and treatment. Cancer registry software plays a crucial role in capturing, organizing, and analyzing data related to drug and medical device exposure, diagnostics, chemotherapy, surgery, and supportive treatments. Organizations such as the European Society of Gastrointestinal Endoscopy and the European Society of Gastroenterology and Endoscopy Nurses and Associates provide valuable guidance in this domain. As healthcare professionals strive to enhance patient care and outcomes, the adoption of cancer registry software facilitates post-endoscopic resection and surgical resection of cancer, enabling better treatment planning and monitoring.

Market Segmentation

In the market, healthcare professionals, researchers, and medical professionals leverage advanced software solutions to address the challenges posed by cancer prevalence and treatment. The adoption of Electronic Health Records (EHR) facilitates the collection and analysis of comprehensive cancer patient registry data, enabling evidence-based medicine and personalized therapeutics. With the global spread of diseases, cancer registries play a vital role in tracking and monitoring cancer-specific outcomes in specific areas. These software solutions empower medical professionals to assess cancer prevalence, treatment efficacy, and patient outcomes, contributing to improved healthcare costs and outcomes. By centralizing and standardizing cancer registry data, healthcare professionals can collaborate more effectively, enhancing research efforts and advancing cancer treatment strategies. The end-user segment of the market continues to drive innovation, supporting the fight against cancer and improving patient care worldwide.

End-user Analysis 

The market share growth by the government and third-party segment will be significant during the forecast period. These software solutions are designed to help government hospitals and third-party agencies collect, manage and analyze data on such cases. Governments use this software to monitor and track cancer incidence, prevalence, and mortality. This data provides important information for public health planning, resource allocation, and policy development.

Get a glance at the market contribution of various segments View a PDF Sample

The government and third party segment was valued at USD 20.64 million in 2017. By analyzing trends and patterns, governments and third parties can identify high-risk populations, geographic differences, and emerging cancers. Governments use software to monitor and improve the quality of care. By analyzing registry data, they can identify differences in treatment practice, assess adherence to clinical guidelines, and compare results to national or international standards. This information can be used to guide efforts to improve the quality and efficiency of cancer care in government hospitals and third-party users, which will fuel the adoption during the forecast period. 

Regional Analysis

For more insights about various regions' market share, View PDF Sample now!

North America is estimated to contribute 51% to the growth of the global market during the forecast period. Technavio’s analysts have explained the regional trends and drivers that will shape the market during the forecast period. In recent years, the adoption of various advanced technologies has risen in North America. Factors such as the high adoption of technology, increasing case burden, favorable government funding to facilitate the development of the registries, increasing investment in health information technology, and rising focus on value-based care are driving the growth of the market in this region. Additionally, the growing presence of a well-known vendor and the introduction of electronic health records (EHRs) in hospitals are driving the growth of the North American market.

Moreover, this registry is used by US hospitals and public organizations to provide a complete record of the patient medical history, diagnosis, treatment, and status of all US cancer patients. In the US, state registries send information to the Centers for Disease Control (CDC) and  NPCR. The National Program of Cancer Registries (NPCR) compares and combines information from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program and the National Vital Statistics System of the CDC. Favorable initiatives undertaken by government organizations in North America help improve the registries in the country. This, will raise the demand among the registry centers and hospitals in this country and fuel the growth of the market in North America during the forecast period.

Buy Now Full Report and Discover More

Market Dynamics and Customer Landscape

The market is witnessing substantial growth driven by the increasing prevalence of cancer worldwide. With the adoption of Electronic Health Records (EHR) and evidence-based medicine practices, medical professionals and researchers are leveraging software solutions to manage cancer patient registry data efficiently. These platforms enable the tracking of cancer-specific outcomes, drug exposures, and treatment modalities such as chemotherapy and surgery. Organizations like the European Society of Gastrointestinal Endoscopy provide guidance documents for post-endoscopic resection and surgical resection of cancer, further contributing to the advancement of cancer treatment methodologies and patient care. There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

The growing prevalence of cancer is the prime reason for the option for cancer registry software. It is one of the most common chronic diseases and is becoming a major health issue as it is increasing the mortality rate globally. Genetic mutations, environmental factors such as tobacco smoking and pollution, and changing dietary patterns are the key factors to raise the cases. The increasing prevalence of such factors has directly contributed to the raised incidence of cancer across the globe. As a result, it has become the second leading cause of death worldwide.

Furthermore, understanding these trends requires registries of cancer-diagnosed populations, treated patients, and mortality rates. Healthcare providers need data on cancer incidence to make decisions about the volume of equipment and drugs to purchase for treatment and to develop awareness and prevention programs. These registries are primarily used to collect, store, and manage data about patients. 

Significant Market Trends

Increasing clinical research for oncology is the key trend driving the growth of the global market. Pharmaceutical and biopharmaceutical companies and research institutes focus on conducting clinical trials to develop new approaches to the treatment. Medical professionals conduct clinical trials to understand the effectiveness of treatments. Clinical trials help to discover new ways to diagnose and treat cancer and reduce the burden of cancer-caused deaths. Randomized clinical trials (RCTs) are designed to compare approaches to care and treatment options. They help to support the clinical decision-making process.

In addition, research institutes and pharmaceutical companies use cancer registries as a follow-up source during phase III and IV clinical trials, and the development of advanced software is supported by public and private cancer registries and help to improve the data quality. This, will enhance clinical research and evaluation of healthcare for reducing the burden of cancer and boost the growth of the market during the forecast period.

Major Market Challenges

Lack of interoperability is a significant challenge that affects the market growth analysis. They primarily contribute to patient care by providing accurate and easily accessible data about patients, treatments received, and results obtained. They are a crucial part of healthcare systems and hospital cancer programs. The adoption of advanced health information technology helps link registration data to electronic health records (EHRs). The introduction of electronic medical records in these registries offers benefits in several areas, including data quality, policy and regulation, reporting, administration, staffing, and training.

Furthermore, these centers and healthcare facilities primarily use different EHR systems, which may pose inefficiency in the clinical workflow. Direct linking of cancer registries with the EHR systems is a major challenge in oncology. The lack of interoperability with electronic medical records (EHR) systems in pull-out data from cancer registries is a challenge that can restrict the demand. This is expected to impede the growth of the global market during the forecast period.

Buy Now Full Report and Discover More

Customer Landscape

The market analysis and report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

Global market Customer Landscape

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

CDC: The company offers cancer-registry software such as Registry Plus.

• Conduent Inc.
• Elekta AB
• ERS Inc.
• Inspirata Inc.
• International Association of Cancer-Registries
• International Business Machines Corp.
• McKesson Corp.
• NeuralFrame Inc.
• OMH HealthEdge Holdings LLC,
• Onco Inc.
• Ordinal Data Inc.
• Redsson Ltd.
• Siemens Healthineers AG
• University of Utah Health

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is witnessing growth spurred by increasing concerns over cancer prevalence and associated healthcare costs. Government initiatives are driving the adoption of the software, aimed at enhancing quality of care and facilitating population health management. These software solutions enable the creation of computerized databases to store and manage patient registry data, aiding in post-marketing surveillance and the analysis of cancer-specific outcomes. They serve as essential tools for government organizations and healthcare providers to track cancer cases and deaths, ultimately supporting population health management efforts. However, privacy and data security-related concerns remain crucial considerations, given the sensitive nature of health information data, including demographic information and personal characteristics such as socioeconomic status.

The market is witnessing significant growth driven by the adoption of Electronic Health Records (EHR) and the increasing focus on evidence-based medicine in the healthcare industry. With the global spread of diseases, specific areas rely on comprehensive solutions like cancer registry software to track and manage patient data effectively. Organizations such as the International Agency for Research on Cancer (IARC) and the Union for International Cancer Control (UICC) utilize cancer registry software to facilitate cancer staging, diagnostics, and patient care management. These solutions support seamless data integration, enabling healthcare providers to store data securely and comply with strict security protocols. By enhancing cancer reporting and supporting medical research, cancer registry software plays a crucial role in improving clinical studies and reducing deaths caused by cancer.

The market is witnessing a surge in demand due to the widespread adoption of EHRs (Electronic Health Records) and the growing need for comprehensive cancer patient registry data management. EHRs play a pivotal role in capturing crucial information related to drug/medical device exposure and treatment outcomes, and therapeutics. Cancer patient registry software enables healthcare organizations to efficiently track chemotherapy, surgery, and supportive treatments, improving patient care and outcomes. Key organizations such as the European Society of Gastrointestinal Endoscopy and the European Society of Gastroenterology and Endoscopy Nurses and Associates rely on guidance documents to enhance Post-endoscopic resection and surgical resection of cancer. This software empowers doctors and medical professionals with comprehensive tools for managing cancer patient data effectively.

Segment Overview

The market growth and trends report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• End-user Outlook 
  • Government and third party
  • Pharma biotech and medical device companies
  • Hospitals and medical practice
  • Private payers
  • Research institutes

• Type Outlook 
  • Stand-alone software
  • Integrated software

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Chile 
    • Brazil
    • Australia

Market Scope
Report Coverage	Details
Page number	173
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 12.13%
Market growth 2023-2027	USD 82.3 million
Market structure	Concentrated
YoY growth 2022-2023(%)	10.92
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 51%
Key countries	US, Canada, Germany, Italy, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	CDC, Conduent Inc., Elekta AB, ERS Inc., Inspirata Inc., International Business Machines Corp., McKesson Corp., NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal Data Inc., Redsson Ltd., Siemens Healthineers AG, and University of Utah Health
Market dynamics	Market trends and analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2023 and 2027
• Precise estimation of the market size and its contribution of the market in focus to the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Competitive landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Market Growth Analysis across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about vendors
• Market forecasting of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch